NASDAQ:SNDX
Decline in SNDX’s short interest indicates Bullish sentiment
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its ...
Recent Insider Activity Suggests Potential Gains for Syndax Pharmaceuticals Inc (SNDX)
Syndax Pharmaceuticals Inc’s recent filing unveils that its Chief Executive Officer Metzger Michael A unloaded Company’s shares for reported $2.58 ...
Syndax Pharmaceuticals Inc (SNDX) receives a Buy rating from H.C. Wainwright
Syndax Pharmaceuticals Inc’s recent filing unveils that its Chief Executive Officer Metzger Michael A unloaded Company’s shares for reported $2.58 ...
H.C. Wainwright’s latest rating for SNDX stock
Syndax Pharmaceuticals Inc’s recent filing unveils that its Chief Executive Officer Metzger Michael A unloaded Company’s shares for reported $2.58 ...
SNDX stock rated a Buy by H.C. Wainwright
In a filing, Syndax Pharmaceuticals Inc revealed its Chief Executive Officer Metzger Michael A unloaded Company’s shares for reported $2.58 ...
Recent Insider Activity Could Benefit Syndax Pharmaceuticals Inc (SNDX)
Syndax Pharmaceuticals Inc’s filing revealed that its Chief Executive Officer Metzger Michael A unloaded Company’s shares for reported $2.58 million ...
A company insider recently sold 157,307 shares of Syndax Pharmaceuticals Inc [SNDX]. Should You also Consider to Sale?
In a filing, Syndax Pharmaceuticals Inc revealed its Chief Executive Officer Metzger Michael A unloaded Company’s shares for reported $2.58 ...
